Artitaya Lophatananon

ORCID: 0000-0003-0550-4657
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • BRCA gene mutations in cancer
  • Genetic Associations and Epidemiology
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Nutrition, Genetics, and Disease
  • Global Cancer Incidence and Screening
  • Genetic factors in colorectal cancer
  • Cancer Risks and Factors
  • Gene expression and cancer classification
  • Estrogen and related hormone effects
  • Molecular Biology Techniques and Applications
  • Cancer Genomics and Diagnostics
  • Bladder and Urothelial Cancer Treatments
  • Genomics and Chromatin Dynamics
  • Epigenetics and DNA Methylation
  • Endometrial and Cervical Cancer Treatments
  • Bioinformatics and Genomic Networks
  • Cancer, Lipids, and Metabolism
  • Cancer-related molecular mechanisms research
  • RNA modifications and cancer
  • Health, Environment, Cognitive Aging
  • Health Systems, Economic Evaluations, Quality of Life
  • CRISPR and Genetic Engineering
  • Pancreatic and Hepatic Oncology Research
  • Genomics and Rare Diseases

Manchester Academic Health Science Centre
2013-2025

University of Manchester
2016-2025

Milliman (United States)
2021-2023

Manado State University
2021-2023

University of Warwick
2011-2022

University of Wisconsin–Madison
2022

Primary Health Care
2019-2021

St Mary's Hospital
2021

Edinburgh Cancer Research
2021

Cancer Research Center
2021

Nasim Mavaddat Leila Dorling Sara Carvalho Jamie Allen Anna González‐Neira and 89 more Renske Keeman Manjeet K. Bolla Joe Dennis Qin Wang Thomas U. Ahearn Irene L. Andrulis Matthias W. Beckmann Sabine Behrens Javier Benı́tez Marina Bermisheva Carl Blomqvist Natalia Bogdanova Stig E. Bojesen Ignacio Briceño Thomas Brüning Nicola J. Camp Archie Campbell Jose E. Castelao Jenny Chang‐Claude Stephen J. Chanock Georgia Chenevix‐Trench Hans Christiansen Kamila Czene Thilo Dörk Mikael Eriksson D. Gareth Evans Peter A. Fasching Jonine D. Figueroa Henrik Flyger Marike Gabrielson Manuela Gago‐Dominguez Jürgen Geisler Graham G. Giles Pascal Guénel Andreas Hadjisavvas Eric Hahnen Per Hall Ute Hamann Jaana M. Hartikainen Mikael Hartman Reiner Hoppe Sacha J. Howell Anna Jakubowska Audrey Jung Э. К. Хуснутдинова Vessela N. Kristensen Jingmei Li Swee Ho Lim Annika Lindblom Maria A. Loizidou Artitaya Lophatananon Jan Lubiński Michael J. Madsen Graham J. Mann Mehdi Manoochehri Sara Margolin Dimitrios Mavroudis Roger L. Milne Nur Aishah Mohd Taib Anna Morra Kenneth Muir Nadia Obi Ana Osório Tjoung‐Won Park‐Simon Paolo Peterlongo Paolo Radice Emmanouil Saloustros Elinor J. Sawyer Rita K. Schmutzler Mitul Shah Xueling Sim Melissa C. Southey Heather Thorne Ian Tomlinson Diana Torres Thérèse Truong Cheng Har Yip Amanda B. Spurdle Maaike P.G. Vreeswijk Alison M. Dunning Montserrat García‐Closas Paul D.P. Pharoah Anders Kvist Taru Muranen Heli Nevanlinna Soo‐Hwang Teo Peter Devilee Marjanka K. Schmidt Douglas F. Easton

Rare germline genetic variants in several genes are associated with increased breast cancer (BC) risk, but their precise contributions to different disease subtypes unclear. This information is relevant guidelines for gene panel testing and risk prediction.To characterize tumors BC susceptibility large-scale population- or hospital-based studies.The multicenter, international case-control analysis of the BRIDGES study included 42 680 patients 46 387 control participants, comprising women...

10.1001/jamaoncol.2021.6744 article EN cc-by JAMA Oncology 2022-01-27
Anqi Wang Jiayi Shen Alex A Rodriguez Edward J. Saunders Fei Chen and 95 more Rohini Janivara Burcu F. Darst Xin Sheng Yili Xu Alisha Chou Sara Benlloch Tokhir Dadaev Mark N. Brook Anna Plym Ali Sahimi Thomas J Hoffman Atushi Takahashi Koichi Matsuda Yukihide Momozawa Masashi Fujita Triin Laisk Jéssica Figuerêdo Kenneth Muir Shuji Ito Xiaoxi Liu Yuji Uchio Michiaki Kubo Yoichiro Kamatani Artitaya Lophatananon Peggy Wan Caroline Andrews Adriana Lori Parichoy Pal Choudhury Johanna Schleutker Teuvo L.J. Tammela Csilla Sipeky Anssi Auvinen Graham G. Giles Melissa C. Southey Robert J. MacInnis Cezary Cybulski Dominika Wokołorczyk Jan Lubiński Christopher T. Rentsch Kelly Cho Benjamin H. McMahon David E. Neal Jenny L. Donovan Freddie C. Hamdy Richard M. Martin Børge G. Nordestgaard Sune F. Nielsen Maren Weischer Stig E. Bojesen Martin Andreas Røder Hein Vincent Stroomberg Jyotsna Batra Suzanne K. Chambers Lisa G. Horvath Judith A. Clements Wayne Tilly Gail P. Risbridger Henrik Grönberg Markus Aly Robert Szulkin Martin Eklund Tobias Nordström Nora Pashayan Alison M. Dunning Maya Ghoussaini Ruth C. Travis Timothy J. Key Elio Ríboli Jong Y. Park Thomas A. Sellers Hui-Yi Lin Demetrius Albanes Stephanie J. Weinstein Michael B. Cook Lorelei A. Mucci Edward Giovannucci Sara Lindström Peter Kraft David J. Hunter Kathryn L. Penney Constance Turman Catherine M. Tangen Phyllis J. Goodman Ian M. Thompson Robert J. Hamilton Neil E. Fleshner Antonio Finelli Marie‐Élise Parent Janet L. Stanford Elaine A. Ostrander Stella Koutros Laura E. Beane Freeman Meir Stampfer Alicja Wolk Niclas Håkansson

10.1038/s41588-023-01534-4 article EN Nature Genetics 2023-11-09

Polygenic risk scores (PRS) have been shown to predict breast cancer in European women, but their utility Asian women is unclear. Here we evaluate the best performing PRSs for European-ancestry using data from 17,262 cases and 17,695 controls of ancestry 13 case-control studies, 10,255 Chinese a prospective cohort (413 incident cancers). Compared middle quintile distribution, highest 1% PRS distribution ~2.7-fold lowest has ~0.4-fold developing cancer. There no evidence heterogeneity...

10.1038/s41467-020-17680-w article EN cc-by Nature Communications 2020-07-31

Background Various risk factors have been associated with epithelial ovarian cancer in observational epidemiological studies. However, the causal nature of reported, and thus their suitability as effective intervention targets, is unclear given susceptibility conventional designs to residual confounding reverse causation. Mendelian randomization (MR) uses genetic variants proxies for strengthen inference We used MR evaluate association 12 previously reported (reproductive, anthropometric,...

10.1371/journal.pmed.1002893 article EN cc-by PLoS Medicine 2019-08-07
Leila Dorling Sara Carvalho Jamie Allen Michael T. Parsons Cristina Fortuño and 95 more Anna González‐Neira Stephan Heijl Muriel A. Adank Thomas U. Ahearn Irene L. Andrulis Päivi Auvinen Heiko Becher Matthias W. Beckmann Sabine Behrens Marina Bermisheva Natalia Bogdanova Stig E. Bojesen Manjeet K. Bolla Michael Bremer Ignacio Briceño Nicola J. Camp Archie Campbell Jose E. Castelao Jenny Chang-Claude Stephen J. Chanock Georgia Chenevix‐Trench J. Margriet Collée Kamila Czene Joe Dennis Thilo Dörk Mikael Eriksson D. Gareth Evans Peter A. Fasching Jonine D. Figueroa Henrik L. Flyger Marike Gabrielson Manuela Gago‐Dominguez Montserrat García‐Closas Graham G. Giles Gord Glendon Pascal Guénel Melanie Gündert Andreas Hadjisavvas Eric Hahnen Per Hall Ute Hamann Elaine F. Harkness Mikael Hartman Frans B.L. Hogervorst Antoinette Hollestelle Reiner Hoppe Sacha J. Howell Anna Jakubowska Audrey Jung Elza Khusnutdinova Sung-Won Kim Yon‐Dschun Ko Vessela N. Kristensen Inge M.M. Lakeman Jingmei Li Annika Lindblom Maria A. Loizidou Artitaya Lophatananon Jan Lubiński Craig Luccarini Michael J. Madsen Arto Mannermaa Mehdi Manoochehri Sara Margolin Dimitrios Mavroudis Roger L. Milne Nur Aishah Mohd Taib Kenneth Muir Heli Nevanlinna William G. Newman Jan C. Oosterwijk Sue K. Park Paolo Peterlongo Paolo Radice Emmanouil Saloustros Elinor J. Sawyer Rita K. Schmutzler Mitul Shah Xueling Sim Melissa C. Southey Harald Surowy Maija Suvanto Ian Tomlinson Diana Torres Thérèse Truong Christi J. van Asperen Regina Waltes Qin Wang Xiaohong R. Yang Paul D.P. Pharoah Marjanka K. Schmidt Javier Benı́tez Bas Vroling Alison M. Dunning Soo‐Hwang Teo

Protein truncating variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2 are associated with increased breast cancer risk, but risks missense these genes uncertain. We analyzed data on 59,639 cases 53,165 controls from studies participating the Breast Cancer Association Consortium BRIDGES project. sampled training (80%) validation (20%) sets to analyze rare ATM (1146 variants), BRCA1 (644), BRCA2 (1425), CHEK2 (325), (472). evaluated according five silico prediction-of-deleteriousness algorithms,...

10.1186/s13073-022-01052-8 article EN cc-by Genome Medicine 2022-05-18
Hermela Shimelis Romy L.S. Mesman Catharina Von Nicolai Åsa Ehlén Lucia Guidugli and 95 more Charlotte Martin Fabienne M.G.R. Calléja Huong Meeks Emily Hallberg Jamie Hinton Jenna Lilyquist Chunling Hu Cora M. Aalfs Kristiina Aittomäki Irene L. Andrulis Hoda Anton‐Culver Volker Arndt Matthias W. Beckmann Javier Benı́tez Natalia Bogdanova Stig E. Bojesen Manjeet K. Bolla Anne‐Lise Børresen‐Dale Hiltrud Brauch Paul Brennan Hermann Brenner Annegien Broeks Barbara Brouwers Thomas Brüning Barbara Burwinkel Jenny Chang‐Claude Georgia Chenevix‐Trench Ching‐Yu Cheng Ji‐Yeob Choi J. Margriet Collée Angela Cox Simon S. Cross Kamila Czene Hatef Darabi Joe Dennis Thilo Dörk Isabel dos‐Santos‐Silva Alison M. Dunning Peter A. Fasching Jonine D. Figueroa Henrik Flyger Montserrat García‐Closas Graham G. Giles Gord Glendon Pascal Guénel Christopher A. Haiman Per Hall Ute Hamann Mikael Hartman Frans B.L. Hogervorst Antoinette Hollestelle John L. Hopper Hidemi Ito Anna Jakubowska Daehee Kang Veli‐Matti Kosma Vessela N. Kristensen Kah-Nyin Lai Diether Lambrechts Loı̈c Le Marchand Jingmei Li Annika Lindblom Artitaya Lophatananon Jan Lubiński Eva Macháčková Graham J. Mann Sara Margolin Frederik Marmé Keitaro Matsuo Hui Miao Kyriaki Michailidou Roger L. Milne Kenneth Muir Susan L. Neuhausen Heli Nevanlinna Janet E. Olson Curtis Olswold Jan J.C. Oosterwijk Ana Osório Paolo Peterlongo Julian Peto Paul D.P. Pharoah Katri Pylkäs Paolo Radice Muhammad Usman Rashid Valerie Rhenius Anja Rudolph Suleeporn Sangrajrang Elinor J. Sawyer Marjanka K. Schmidt Minouk J. Schoemaker Caroline Seynaeve Mitul Shah Chen‐Yang Shen Martha J. Shrubsole

Breast cancer risks conferred by many germline missense variants in the

10.1158/0008-5472.can-16-2568 article EN Cancer Research 2017-03-11

10.1016/j.eururo.2018.10.025 article EN European Urology 2018-10-29
Maya Ghoussaini Juliet D. French Kyriaki Michailidou Silje Nord Jonathan Beesley and 95 more Sander Canisus Kristine M. Hillman Susanne Kaufmann Haran Sivakumaran Mahdi Moradi Marjaneh Jason S. Lee Joe Dennis Manjeet K. Bolla Sophia Wang Ed Dicks Roger L. Milne John L. Hopper Melissa C. Southey Marjanka K. Schmidt Annegien Broeks Kenneth Muir Artitaya Lophatananon Peter A. Fasching Matthias W. Beckmann Olivia Fletcher Nichola Johnson Elinor J. Sawyer Ian Tomlinson Barbara Burwinkel Frederik Marmé Pascal Guénel Thérèse Truong Stig E. Bojesen Henrik Flyger Javier Benı́tez Anna González‐Neira M. Rosario Alonso Guillermo Pita Susan L. Neuhausen Hoda Anton‐Culver Hermann Brenner Volker Arndt Alfons Meindl Rita K. Schmutzler Hiltrud Brauch Ute Hamann Daniel C. Tessier Daniel Vincent Heli Nevanlinna Sofia Khan Keitaro Matsuo Hidemi Ito Thilo Dörk Natalia Bogdanova Annika Lindblom Sara Margolin Graham J. Mann Veli‐Matti Kosma Anna H. Wu David Van Den Berg Diether Lambrechts Giuseppe Floris Jenny Chang‐Claude Anja Rudolph Paolo Radice Monica Barile Fergus J. Couch Emily Hallberg Graham G. Giles Christopher A. Haiman Loı̈c Le Marchand Mark S. Goldberg Soo‐Hwang Teo Cheng Har Yip Anne‐Lise Børresen‐Dale Wei Zheng Qiuyin Cai Robert Winqvist Katri Pylkäs Irene L. Andrulis Peter Devilee Rob A.�E.�M. Tollenaar Montserrat García‐Closas Jonine D. Figueroa Per Hall Kamila Czene Judith S. Brand Hatef Darabi Mikael Eriksson Maartje J. Hooning Linetta B. Koppert Jingmei Li Xiao‐Ou Shu Ying Zheng Angela Cox Simon S. Cross Mitul Shah Valerie Rhenius Ji‐Yeob Choi Daehee Kang

Genome-wide association studies (GWASs) have revealed increased breast cancer risk associated with multiple genetic variants at 5p12. Here, we report the fine mapping of this locus using data from 104,660 subjects 50 case-control in Breast Cancer Association Consortium (BCAC). With for 3,365 genotyped and imputed SNPs across a 1 Mb region (positions 44,394,495–45,364,167; NCBI build 37), found evidence least three independent signals: strongest signal, consisting single SNP rs10941679, was...

10.1016/j.ajhg.2016.07.017 article EN cc-by The American Journal of Human Genetics 2016-09-15

Introduction Over 80% of the nearly 1 million men diagnosed with prostate cancer annually worldwide present localised or locally advanced non-metastatic disease. Risk stratification is cornerstone for clinical decision making and treatment selection these men. The most widely applied systems use presenting prostate-specific antigen (PSA) concentration, biopsy Gleason grade, stage to classify patients as low, intermediate, high risk. There is, however, significant heterogeneity in outcomes...

10.1371/journal.pmed.1002063 article EN cc-by PLoS Medicine 2016-08-02

Non-European populations are under-represented in genetics studies, hindering clinical implementation of breast cancer polygenic risk scores (PRSs). We aimed to develop PRSs using the largest available studies Asian ancestry and assess transferability PRS across ethnic subgroups.

10.1016/j.gim.2021.11.008 article EN publisher-specific-oa Genetics in Medicine 2021-12-15

Objectives To investigate the association between shingles and dementia, Zostavax vaccination dementia. Design Nested case–control study. Settings Data were drawn from UK Biobank cohort study with a total of 228 223 participants Hospital Episodes Statistics primary care linkage health records. Participants The analyses included 2378 incident dementia cases 225 845 controls. Inclusion criteria for diagnosis 3 years or more after first assessment date derived all sources including...

10.1136/bmjopen-2020-045871 article EN BMJ Open 2021-10-01

Abstract Background Dementia affects ability to remember, think, or make decisions that interfere with doing everyday activities. There is no cure, therefore any prevention delay of the onset importance. This study aims investigate association between zoster and influenza vaccinations risk developing dementia. Methods We conducted a retrospective population-based cohort using electronic health records from 1469 general practices contributing Clinical Practice Research Datalink (CPRD) Aurum...

10.1186/s12889-023-16768-4 article EN cc-by BMC Public Health 2023-10-02

Abstract Background DNA methylation plays a critical role in breast cancer development. Previous studies have identified marks white blood cells as promising biomarkers for cancer. However, these were limited by low statistical power and potential biases. Using new methodology, we investigated their associations with risk. Methods Statistical models built to predict levels of using genetic data from HumanMethylation450 BeadChip the Framingham Heart Study (n = 1595). The prediction validated...

10.1093/jnci/djz109 article EN JNCI Journal of the National Cancer Institute 2019-05-23

The purpose of this study is to validate a new five-tiered prognostic classification system better discriminate cancer-specific mortality in men diagnosed with primary non-metastatic prostate cancer. We applied recently described five-strata model, the Cambridge Prognostic Groups (CPGs 1-5), two international cohorts and tested performance against current standard three-strata low-, intermediate- or high-risk disease. Diagnostic clinico-pathological data for obtained from Prostate Cancer...

10.1186/s12916-018-1019-5 article EN cc-by BMC Medicine 2018-02-28

Previous studies have shown that reproductive factors are differentially associated with breast cancer (BC) risk by subtypes. The aim of this study was to investigate associations between and BC subtypes, whether these vary age at diagnosis. We used pooled data on tumor markers (estrogen progesterone receptor, human epidermal growth factor receptor-2 (HER2)) (parity, first full-time pregnancy (FFTP) menarche) from 28,095 patients invasive 34 participating in the Breast Cancer Association...

10.1186/s13058-017-0909-3 article EN cc-by Breast Cancer Research 2017-11-07

This study was designed to investigate the relationship between a systematic inflammatory biomarker measure, concurrent and later cognitive performance, future dementia risk. The literature has reported potential involvement of inflammation in performance as well Alzheimer’s Disease, but not consistently. We used population-based cohort 500,000 people UK assessed association composite measures across five domains measured concurrently 4–13 years later, taking advantage large sample size....

10.1371/journal.pone.0288045 article EN cc-by PLoS ONE 2023-07-19

Meningiomas account for up to 37% of all primary brain tumors. Genetic susceptibility meningioma is well established, with the risk among relatives patients being approximately threefold higher than that in general population. A relationship between and exposure ionizing radiation also known led us examine whether variants DNA repair genes contribute disease susceptibility.We analyzed 1127 tagging single-nucleotide polymorphisms (SNPs) were selected capture most common variation 136 five...

10.1093/jnci/djn004 article EN JNCI Journal of the National Cancer Institute 2008-02-13

Genetic variation at the TERT-CLPTM1L locus 5p15.33 is associated with susceptibility to several cancers, including epithelial ovarian cancer (EOC). We have carried out fine-mapping of this region in EOC which implicates an association a single nucleotide polymorphism (SNP) within TERT promoter. demonstrate that minor alleles rs2736109, and additional promoter SNP, rs2736108, are decreased breast risk, combination both SNPs substantially reduces activity.

10.1371/journal.pone.0024987 article EN cc-by PLoS ONE 2011-09-15
Nichola Johnson Frank Dudbridge Nick Orr Lorna J. Gibson Michael E. Jones and 95 more Minouk J. Schoemaker Elizabeth Folkerd Ben P. Haynes John L. Hopper Melissa C. Southey Gillian S. Dite Carmel Apicella Marjanka K. Schmidt Annegien Broeks Laura J. vanʼt Veer Femke Atsma Kenneth Muir Artitaya Lophatananon Peter A. Fasching Matthias W. Beckmann Arif B. Ekici Stefan P. Renner Elinor J. Sawyer Ian Tomlinson Michael J. Kerin Nicola Miller Barbara Burwinkel Frederik Marmé Andreas Schneeweiß Christof Sohn Pascal Guénel Thérèse Truong Emilie Cordina F. Ménégaux Stig E. Bojesen Børge G. Nordestgaard Henrik Flyger Roger L. Milne M. Pilar Zamora José Ignacio Arias Pérez Javier Benı́tez Leslie Bernstein Hoda Anton‐Culver Argyrios Ziogas Christina Clarke Dur Hermann Brenner Heiko Müller Volker Arndt Aida Karina Dieffenbach Alfons Meindl Joerg Heil Claus R. Bartram Rita K. Schmutzler Hiltrud Brauch Christina Justenhoven Yon‐Dschun Ko Heli Nevanlinna Taru Muranen Kristiina Aittomäki Carl Blomqvist Keitaro Matsuo Thilo Dörk Natalia Bogdanova Natalia Antonenkova Annika Lindblom Graham J. Mann Vesa Kataja Veli-Matti Kosma Jaana M. Hartikainen Georgia Chenevix‐Trench Jonathan Beesley Anna H. Wu David Van Den Berg Chiu-Chen Tseng Diether Lambrechts Dominiek Smeets Patrick Neven Hans Wildiers Jenny Chang‐Claude Anja Rudolph Stefan Nickels Dieter Flesch‐Janys Paolo Radice Paolo Peterlongo Bernardo Bonanni Valeria Pensotti Fergus J. Couch Janet E. Olson Xianshu Wang Zachary Fredericksen V. Shane Pankratz Graham G. Giles Gianluca Severi Laura Baglietto C.A. Haiman Jacques Simard Mark S. Goldberg France Labrèche Martine Dumont Penny Soucy

Abstract Introduction We have previously shown that a tag single nucleotide polymorphism (rs10235235), which maps to the CYP3A locus (7q22.1), was associated with reduction in premenopausal urinary estrone glucuronide levels and modest risk of breast cancer women age ≤50 years. Methods further investigated association rs10235235 large case control study 47,346 cases 47,570 controls from 52 studies participating Breast Cancer Association Consortium. Genotyping conducted using custom Illumina...

10.1186/bcr3662 article EN cc-by Breast Cancer Research 2014-05-26

Background Anthropometric and reproductive factors have been reported as being established risk for breast cancer (BC). This study explores the contribution of anthropometric in UK females developing BC a large longitudinal cohort. Methods Data from Biobank prospective 273,467 were analyzed. Relative risks (RRs) 95% confidence intervals (CIs) each factor adjusted age, family history deprivation score. The analyses stratified by menopausal status. Results Over 9 years follow up total number...

10.1371/journal.pone.0201097 article EN cc-by PLoS ONE 2018-07-26
Hatef Darabi Karen McCue Jonathan Beesley Kyriaki Michailidou Silje Nord and 95 more Siddhartha Kar Keith Humphreys Deborah Thompson Maya Ghoussaini Manjeet K. Bolla Joe Dennis Sophia Wang Sander Canisius Christopher G. Scott Carmel Apicella John L. Hopper Melissa C. Southey Jennifer Stone Annegien Broeks Marjanka K. Schmidt Rodney J. Scott Artitaya Lophatananon Kenneth Muir Matthias W. Beckmann Arif B. Ekici Peter A. Fasching Katharina Heusinger Isabel dos‐Santos‐Silva Julian Peto Ian Tomlinson Elinor J. Sawyer Barbara Burwinkel Frederik Marmé Pascal Guénel Thérèse Truong Stig E. Bojesen Henrik Flyger Javier Benı́tez Anna González‐Neira Hoda Anton‐Culver Susan L. Neuhausen Volker Arndt Hermann Brenner Christoph Engel Alfons Meindl Rita K. Schmutzler Norbert Arnold Hiltrud Brauch Ute Hamann Jenny Chang‐Claude Sofia Khan Heli Nevanlinna Hidemi Ito Keitaro Matsuo Natalia Bogdanova Thilo Dörk Annika Lindblom Sara Margolin Veli‐Matti Kosma Graham J. Mann Chiu-Chen Tseng Anna H. Wu Giuseppe Floris Diether Lambrechts Anja Rudolph Paolo Peterlongo Paolo Radice Fergus J. Couch Celine M. Vachon Graham G. Giles Catriona McLean Roger L. Milne Pierre‐Antoine Dugué Christopher A. Haiman Gertraud Maskarinec Christy Woolcott Brian E. Henderson Mark S. Goldberg Jacques Simard Soo‐Hwang Teo Shivaani Mariapun Åslaug Helland Vilde Drageset Haakensen Wei Zheng Alicia Beeghly‐Fadiel Rulla M. Tamimi Arja Jukkola‐Vuorinen Robert Winqvist Irene L. Andrulis Julia A. Knight Peter Devilee Robert A.E.M. Tollenaar Jonine D. Figueroa Montserrat García‐Closas Kamila Czene Maartje J. Hooning Madeleine M.A. Tilanus‐Linthorst Jingmei Li Yu‐Tang Gao Xiao‐Ou Shu

10.1016/j.ajhg.2015.05.002 article EN publisher-specific-oa The American Journal of Human Genetics 2015-06-13
Coming Soon ...